Pitt Researcher to Receive Sadie Gerson Distinguished Scholar Award
PITTSBURGH, Sept. 14, 2010 – Nearly 100 physicians, patients and friends will gather on Thursday, September 16, at the Hillman Cancer Center to honor Robert E. Schoen, M.D., M.P.H., professor of medicine and epidemiology at the University of Pittsburgh, as he receives the Sadie Gerson Distinguished Scholar Award, established by Sandy Gerson Snyder.
Dr. Schoen, a leader in the field of early detection and prevention of colorectal cancer, will give an update on his research exploring a vaccine to prevent development of colorectal cancer. In addition to Dr. Schoen’s talk, brief overviews will be given by the following world-renowned physician-researchers:
- Highlights of the PLCO Cancer Screening Trial – Joel Weissfeld, M.D., M.P.H., co-leader of the University of Pittsburgh Cancer Institute’s (UPCI) Cancer Epidemiology, Prevention and Control Program
- Black Raspberries and Colorectal Cancer – Gary Stoner, Ph.D., professor, division of hematology/oncology at The Ohio State University
- Encouraging Colorectal Cancer Screening – Bruce Ling, M.D., M.P.H., associate professor of medicine, University of Pittsburgh School of Medicine
- Molecular Staging in Colorectal Cancer – Scott Waldman, M.D., M.P.H., professor of pharmacology, Thomas Jefferson University, Jefferson Medical College
- Regional Chemotherapy for Advanced Disease – David Bartlett, M.D., chief of the Division of Surgical Oncology, University of Pittsburgh School of Medicine
The Sadie Gerson Distinguished Scholar Award was established in December 2009, by Sandy Gerson Snyder in memory of her mother, Sadie Gerson, who passed away from colon cancer at the age of 51. The award supports educational programs for faculty and staff at the University of Pittsburgh School of Medicine as well as the community at large, with the goal of broadening horizons and pushing the boundaries of knowledge as scientists, physicians and patients work together in the fight against colorectal cancer.
“I am incredibly honored to receive this award,” said Dr. Schoen. “It is the support, compassion and commitment of people like Sandy Gerson Snyder that help us improve our understanding and our ability to eliminate important public health problems like colorectal cancer.”
University of Pittsburgh School of Medicine
As one of the nation’s leading academic centers for biomedical research, the University of Pittsburgh School of Medicine integrates advanced technology with basic science across a broad range of disciplines in a continuous quest to harness the power of new knowledge and improve the human condition. Driven mainly by the School of Medicine and its affiliates, Pitt has ranked among the top 10 recipients of funding from the National Institutes of Health since 1997 and now ranks fifth in the nation, according to NIH data for 2008 (the most recent year for which the data are final).
Likewise, the School of Medicine is equally committed to advancing the quality and strength of its medical and graduate education programs, for which it is recognized as an innovative leader, and to training highly skilled, compassionate clinicians and creative scientists well-equipped to engage in world-class research. The School of Medicine is the academic partner of UPMC, which has collaborated with the University to raise the standard of medical excellence in Pittsburgh and to position health care as a driving force behind the region’s economy. For more information about the School of Medicine, see www.medschool.pitt.edu.